On Feb 14, 2022 Variantyx closed a Series C round and raised $41,500,000 from 20/20 HealthCare Partners, New Era Capital Partners, Peregrine Ventures, Pitango Venture […]
Series C – Koneksa Health
On Feb 7, 2022 Koneksa Health closed a Series C round and raised $45,000,000 from dRx Capital, Matrix Capital Management, McKesson Ventures, Merck Global Health […]
Series C – Dewpoint Therapeutics
On Feb 3, 2022 Dewpoint Therapeutics closed a Series C round and raised $150,000,000 from 3E Bioventures, ARCH Venture Partners, EcoR1 Capital, General Catalyst, Leaps […]
Series C – Enable Injections
On Jan 27, 2022 Enable Injections closed a Series C round and raised $215,000,000 from Cincinnati Children’s, CincyTech, Cintrifuse, GCM Grosvenor, Magnetar Capital, Ohio Innovation […]
Series C – Eucalyptus
On Jan 27, 2022 Eucalyptus closed a Series C round and raised A$60,000,000 from AirTree Ventures, Athletic Ventures, Blackbird Ventures, Bond, NewView Capital, OneVentures, W23, […]
Series C – Enable Injections
On Jan 27, 2022 Enable Injections closed a Series C round and raised $215,000,000 from Cincinnati Children’s, CincyTech, Cintrifuse, GCM Grosvenor, Magnetar Capital, Ohio Innovation […]
Series C – BenchSci
On Jan 24, 2022 BenchSci closed a Series C round and raised CA$63,000,000 from Inovia Capital, TCV, featuring lead investors Inovia Capital, TCV. About the […]
Series C – SiBionics
On Jan 21, 2022 SiBionics closed a Series C round and raised $126,000,000 from C&D Emerging Investment, Cedarlake Capital, China Life Investment Holding, CPE, Fortune […]
Series C – Zhenge Biotech
On Jan 11, 2022 Zhenge Biotech closed a Series C round and raised $100,000,000 from Cowin Capital, Goldman Sachs Asset Management, IDG Capital, Junxin Yingtai […]
Series C – Transcarent
On Jan 11, 2022 Transcarent closed a Series C round and raised $200,000,000 from 7wire Ventures, Ally Bridge Group, Alta Partners, General Catalyst, GreatPoint Ventures, […]
